1 asset in Microvillus Inclusion Disease
Therapeutic assets addressing Microvillus Inclusion Disease, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Crofelemer Microvillus Inclusion Disease | Napo Pharmaceuticals, Inc. | P2/3 | B (57) |